Discussing the pivotal factor behind the UK’s economic uptake:

The COVID-19 Vaccine

    Get Your Copy Now!

    Read our take on the science, the economic impacts and expectations of the ‘new normal’

    After months of anticipation, the race to produce an effective Covid-19 vaccination is well underway as the Uk approves the Pfizer-BioNTech vaccine for imminent mass distribution. With this positivity comes the hope of economic prosperity just around the corner, as this vaccination presents for many the conclusion to a challenging time in our history.

    Instant Download - Grab Your Copy Today!

    DOWNLOAD
    The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

    [Article 48(4) Financial Services and Markets Act 2000 (Financial Promotion) Order 2005]

    Please note that as a responsible company we require the self-certification of either a High Net Worth Investor or Sophisticated Investor statement prior to issuing any detailed information by way of an Investment Memorandum.

    View our Privacy Policy

    Connecting registered investors with opportunities in property development to deliver projects with industry beating returns.
    Main Menu

    Investments

    FAQ

    About Us

    What We Do

    News

    Partners

    Register Your Client Details

    Get In Touch

    Contact Us

    Accumulate Canterbury:
    Canterbury Innovation Centre, University Road, Canterbury CT2 7FG

    Accumulate London:
    The Beehive, Beehive Ring Road, Crawley, Gatwick RH6 0PA

    Accumulate Hong Kong:
    Hong Kong Plaza, 188 Connaught Road West. Hong Kong

    Email: info@accumulatecapital.co.uk

    Tel: 01227 936 996

    © 2020. Accumulate | Privacy Policy | Sitemap
    Disclaimer: Accumulate Capital Limited is registered in England and Wales under company number 11954225. Its registered address is Canterbury Innovation Centre, University Road, Canterbury, England, CT2 7FG.

    Accumulate Capital Limited is not authorised or regulated by the Financial Conduct Authority under the Financial Services and Markets Act 2000 (“FSMA”). The information contained in this web site does not amount to a financial promotion for the purposes of section 21 FSMA.

    This webpage is provided for general information only and nothing contained in the material constitutes a recommendation for the purchase or sale of any security.

    Past performance is not indicative of future results: prices can go up or down. Any investment carries risk as such any person considering an investment should seek independent advice on the suitability or otherwise of a particular investment.

    Accumulate Capital Limited does not provide legal and/or tax advice and as such clients should seek independent legal and/or tax advice regarding the consequences of his/her investment transactions.